Activated T-Cells Expressing 2nd or 3rd Generation CD19-Specific CAR, Advanced B-Cell NHL, ALL, and CLL (SAGAN)

NCT01853631 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

64

Enrollment

OTHER

Sponsor class

Conditions

Non-Hodgkin Lymphoma
Chronic Lymphocytic Leukemia
Acute Lymphocytic Leukemia

Interventions

GENETIC: Dose Escalation Phase:CD19.CAR/28 and CD19.CAR/28137 T cells
GENETIC: Expansion Phase: CD19.CAR/28 and CD19.CAR/28137 T cells

Sponsor

Baylor College of Medicine

Collaborators

[object Object]
[object Object]